Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations
Clinical Immunology · 2024
DOI: 10.1016/j.clim.2024.110299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von S E Detiger und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Rotterdam Eye Hospital, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Mutation, MAP Kinase Signaling System, Xanthomatosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Stichting Wetenschappelijk Onderzoek Oogziekenhuis.
Abstract (Originalsprache)
Adult orbital xanthogranulomatous disease (AOXGD) is a spectrum of histiocytoses with four subtypes. Mitogen-activated protein kinase (MAPK) pathway mutations have been detected in various histiocytic neoplasms, little is known about this in AOXGD. Targeted regions of cancer- and histiocytosis-related genes were analyzed and immunohistochemical staining of phosphorylated ERK (pERK), cyclin D1 and PU.1 was performed in 28 AOXGD and 10 control xanthelasma biopsies to assess MAPK pathway activation. Mutations were detected in 7/28 (25%) patients. Positive staining for pERK and/or cyclin D1 was found across all subtypes in 17/27 (63%) patients of whom 12/17 (71%) did not harbour a mutation. Xanthelasma tissue stained negative for pERK and cyclin D1. Relapse occurred in 5/7 (71%) patients with a MAPK pathway mutation compared to 8/21 (38%) patients in whom no mutation could be detected. Molecular analysis and evaluation for systemic disease is warranted to identify patients at risk of recurrent xanthomatous disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Rotterdam Eye Hospital, Rotterdam, the Netherlands.
- The Rotterdam Eye Hospital, Department of Oculoplastic, Orbital and Lacrimal Surgery, Rotterdam, the Netherlands; Department of Ophthalmology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Internal Medicine, section Clinical Immunology & Allergology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherl…
- Department of Internal Medicine, section Clinical Immunology & Allergology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Immunology, Erasmus MC University Medical Center Rott…
- The Rotterdam Eye Hospital, Rotterdam, the Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands; Department of Pathology, section Ophthalmic Pathology, Erasmus MC University Me…
Förderung
- Stichting Wetenschappelijk Onderzoek Oogziekenhuis
Zitieren
APA
Detiger, S. E., Paridaens, D., Kemps, P. G., van Halteren, A. G. S., van Hagen, P. M., van Laar, J. A. M., & Verdijk, R. M. (2024). Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110299
Vancouver
Detiger SE, Paridaens D, Kemps PG, van Halteren AGS, van Hagen PM, van Laar JAM, et al. Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110299
BibTeX
@article{Detiger2024,
author = {Detiger, S E and Paridaens, D and Kemps, P G and van Halteren, A G S and van Hagen, P M and van Laar, J A M and Verdijk, R M},
title = {Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations},
journal = {Clinical Immunology},
year = {2024},
doi = {10.1016/j.clim.2024.110299}
}
EUVIMED